Clinical Trial Update: PCOS Treatment Using DLBS3233, Metformin, and Combination of Both [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating DLBS3233, metformin, and their combination for Polycystic Ovary Syndrome (PCOS) with insulin resistance; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Polycystic Ovary Syndrome

Drugs mentioned

• DLBS3233
• metformin (metformin)

Snippet

Sponsor: Dexa Medica Group | Conditions: Polycystic Ovary Syndrome (PCOS), Insulin Resistance | Phase 3 | Status: COMPLETED